Extracorporeal myoglobin elimination using the adsorber CytoSorb or the high-flux HF80 dialyzer for patients with severe rhabdomyolysis: a comparative study
Our analysis showed that using CytoSorb resulted in myoglobin reduction rates and clinical outcomes similar to those achieved with CVVHDF with the high-flux HF80 dialyzer for patients with rhabdomyolysis and AKI.
Authors
- Bartosz Tyczynski
- Kristina Schönfelder
- Kristina Boss (ORCID: https://orcid.org/0000-0001-8747-5604)
- Anja Gaeckler
- Andreas Kribben (ORCID: https://orcid.org/0000-0003-4859-7507)
- Julia Omar (ORCID: https://orcid.org/0000-0003-4165-2673)
- Christina Scharf (ORCID: https://orcid.org/0000-0002-5310-4116)
- Michael Jahn (ORCID: https://orcid.org/0000-0002-7493-205X)
- Justa Friebus‐Kardash
Institutions
- LMU Klinikum (DE)
- Essen University Hospital (DE)
- University of Duisburg-Essen (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Clinical Kidney Journal
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1093/ckj/sfaf071
- Citations
- 1
- Primary Topic
- Muscle and Compartmental Disorders
- Type
- article
- Field-Weighted Citation Impact
- 2.01